Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Transplantation | 36 | 2024 | 3233 | 5.360 |
Why?
|
Graft Rejection | 16 | 2024 | 4445 | 1.910 |
Why?
|
Heart Defects, Congenital | 10 | 2024 | 4671 | 0.950 |
Why?
|
Heart Failure | 14 | 2024 | 11669 | 0.880 |
Why?
|
Graft Survival | 8 | 2024 | 3819 | 0.850 |
Why?
|
Heart Diseases | 4 | 2023 | 2781 | 0.830 |
Why?
|
Chickenpox | 1 | 2022 | 96 | 0.770 |
Why?
|
Immunosuppressive Agents | 7 | 2023 | 4174 | 0.770 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2016 | 3492 | 0.690 |
Why?
|
Blood Group Incompatibility | 1 | 2020 | 135 | 0.660 |
Why?
|
Cardiomyopathies | 4 | 2024 | 1964 | 0.580 |
Why?
|
Child | 43 | 2024 | 80153 | 0.560 |
Why?
|
Coronary Disease | 2 | 2023 | 5914 | 0.520 |
Why?
|
Tissue and Organ Procurement | 2 | 2022 | 961 | 0.510 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2020 | 829 | 0.480 |
Why?
|
Tissue Donors | 3 | 2024 | 2331 | 0.470 |
Why?
|
Kidney Transplantation | 4 | 2023 | 4234 | 0.460 |
Why?
|
Hypoplastic Left Heart Syndrome | 2 | 2018 | 594 | 0.450 |
Why?
|
Policy | 3 | 2023 | 508 | 0.450 |
Why?
|
Heart-Assist Devices | 5 | 2023 | 1287 | 0.430 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2013 | 321 | 0.430 |
Why?
|
Waiting Lists | 6 | 2024 | 765 | 0.420 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2013 | 127 | 0.410 |
Why?
|
Hospitals, Pediatric | 3 | 2017 | 1860 | 0.390 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2013 | 278 | 0.370 |
Why?
|
Child, Preschool | 21 | 2024 | 42230 | 0.370 |
Why?
|
Transplantation | 1 | 2011 | 219 | 0.350 |
Why?
|
Perioperative Care | 1 | 2017 | 1033 | 0.330 |
Why?
|
ABO Blood-Group System | 2 | 2023 | 380 | 0.330 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 2243 | 0.320 |
Why?
|
Postoperative Complications | 6 | 2024 | 15631 | 0.310 |
Why?
|
Fontan Procedure | 3 | 2021 | 796 | 0.310 |
Why?
|
Myocarditis | 3 | 2021 | 788 | 0.300 |
Why?
|
Vascular Diseases | 2 | 2015 | 1161 | 0.300 |
Why?
|
Antibodies | 2 | 2023 | 2418 | 0.280 |
Why?
|
Echocardiography, Doppler | 1 | 2011 | 897 | 0.280 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2015 | 2010 | 0.270 |
Why?
|
Organ Transplantation | 3 | 2023 | 1157 | 0.270 |
Why?
|
Models, Statistical | 1 | 2021 | 5079 | 0.260 |
Why?
|
Heart-Lung Transplantation | 2 | 2024 | 87 | 0.260 |
Why?
|
Radiopharmaceuticals | 1 | 2015 | 2651 | 0.250 |
Why?
|
Thrombocytosis | 1 | 2005 | 89 | 0.250 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2005 | 192 | 0.250 |
Why?
|
Tacrolimus | 3 | 2023 | 733 | 0.250 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2005 | 287 | 0.240 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2005 | 346 | 0.240 |
Why?
|
Patient Selection | 3 | 2024 | 4244 | 0.230 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2005 | 418 | 0.230 |
Why?
|
Myocardium | 3 | 2020 | 4726 | 0.230 |
Why?
|
Humans | 58 | 2024 | 761504 | 0.230 |
Why?
|
Coronary Angiography | 4 | 2022 | 4471 | 0.230 |
Why?
|
Heart | 2 | 2021 | 4404 | 0.220 |
Why?
|
Death, Sudden, Cardiac | 1 | 2011 | 1555 | 0.220 |
Why?
|
Adolescent | 18 | 2024 | 88319 | 0.210 |
Why?
|
Enalapril | 1 | 2024 | 312 | 0.210 |
Why?
|
Histocompatibility Testing | 1 | 2024 | 712 | 0.200 |
Why?
|
Lighting | 1 | 2023 | 211 | 0.190 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3358 | 0.190 |
Why?
|
Heart Aneurysm | 1 | 2021 | 114 | 0.190 |
Why?
|
Herpesvirus 3, Human | 1 | 2022 | 159 | 0.190 |
Why?
|
Protein-Losing Enteropathies | 1 | 2021 | 45 | 0.190 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2005 | 686 | 0.180 |
Why?
|
Mycophenolic Acid | 1 | 2023 | 348 | 0.180 |
Why?
|
Infant | 13 | 2024 | 36192 | 0.180 |
Why?
|
Retrospective Studies | 17 | 2024 | 80636 | 0.170 |
Why?
|
Translocation, Genetic | 1 | 2005 | 1393 | 0.170 |
Why?
|
Complement Inactivating Agents | 1 | 2019 | 53 | 0.170 |
Why?
|
Biphenyl Compounds | 1 | 2024 | 1007 | 0.170 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2021 | 227 | 0.160 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5671 | 0.160 |
Why?
|
Immune System Diseases | 1 | 2021 | 256 | 0.160 |
Why?
|
Stroke Volume | 2 | 2024 | 5496 | 0.160 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 6485 | 0.160 |
Why?
|
Bronchitis | 1 | 2019 | 196 | 0.160 |
Why?
|
Coronary Artery Disease | 4 | 2022 | 6403 | 0.160 |
Why?
|
Tetrazoles | 1 | 2024 | 909 | 0.160 |
Why?
|
Social Class | 2 | 2024 | 2004 | 0.150 |
Why?
|
Male | 31 | 2024 | 360804 | 0.150 |
Why?
|
Drug Combinations | 1 | 2024 | 2048 | 0.150 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2024 | 1039 | 0.150 |
Why?
|
Phytotherapy | 1 | 2020 | 296 | 0.150 |
Why?
|
Heart Atria | 1 | 2023 | 1345 | 0.140 |
Why?
|
Biopsy | 4 | 2021 | 6766 | 0.140 |
Why?
|
Barth Syndrome | 1 | 2017 | 25 | 0.140 |
Why?
|
Carboxylic Acids | 1 | 2017 | 90 | 0.140 |
Why?
|
Aorta, Abdominal | 1 | 2019 | 625 | 0.140 |
Why?
|
American Heart Association | 1 | 2021 | 1039 | 0.130 |
Why?
|
Clostridium Infections | 1 | 2023 | 558 | 0.130 |
Why?
|
Norwood Procedures | 1 | 2018 | 192 | 0.130 |
Why?
|
Primary Graft Dysfunction | 1 | 2016 | 111 | 0.120 |
Why?
|
Endocardium | 1 | 2016 | 248 | 0.120 |
Why?
|
Acyltransferases | 1 | 2017 | 305 | 0.120 |
Why?
|
Marijuana Smoking | 1 | 2018 | 258 | 0.120 |
Why?
|
Attitude of Health Personnel | 2 | 2020 | 3889 | 0.120 |
Why?
|
Ammonia | 1 | 2015 | 237 | 0.120 |
Why?
|
Female | 24 | 2024 | 392644 | 0.110 |
Why?
|
Iloprost | 1 | 2013 | 25 | 0.110 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 15266 | 0.110 |
Why?
|
Lung Transplantation | 1 | 2022 | 1310 | 0.110 |
Why?
|
Risk Factors | 9 | 2024 | 74206 | 0.110 |
Why?
|
Brazil | 1 | 2017 | 1230 | 0.110 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2024 | 2118 | 0.110 |
Why?
|
Drug Therapy, Combination | 1 | 2023 | 6310 | 0.100 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2015 | 262 | 0.100 |
Why?
|
Central Nervous System Stimulants | 1 | 2021 | 1177 | 0.100 |
Why?
|
Canada | 1 | 2017 | 2122 | 0.100 |
Why?
|
Lipoproteins, HDL | 1 | 2016 | 676 | 0.100 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4111 | 0.100 |
Why?
|
Consensus | 1 | 2021 | 3123 | 0.090 |
Why?
|
Giant Cells | 2 | 2021 | 188 | 0.090 |
Why?
|
Program Development | 1 | 2017 | 1297 | 0.090 |
Why?
|
Microvessels | 1 | 2015 | 577 | 0.090 |
Why?
|
Veins | 1 | 2015 | 768 | 0.090 |
Why?
|
Genetic Variation | 1 | 2005 | 6567 | 0.090 |
Why?
|
Young Adult | 10 | 2023 | 59243 | 0.090 |
Why?
|
Pediatrics | 2 | 2015 | 3589 | 0.090 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2015 | 575 | 0.090 |
Why?
|
Health Care Surveys | 1 | 2017 | 2426 | 0.090 |
Why?
|
Vaccination | 1 | 2022 | 3384 | 0.080 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2019 | 1228 | 0.080 |
Why?
|
Time Factors | 6 | 2020 | 39967 | 0.080 |
Why?
|
Heart Ventricles | 1 | 2021 | 3807 | 0.080 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2013 | 664 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2018 | 2057 | 0.080 |
Why?
|
ROC Curve | 1 | 2016 | 3579 | 0.080 |
Why?
|
Vasodilator Agents | 1 | 2013 | 973 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2017 | 1600 | 0.080 |
Why?
|
HLA Antigens | 1 | 2013 | 1328 | 0.070 |
Why?
|
Transplantation, Homologous | 2 | 2020 | 4806 | 0.070 |
Why?
|
United States | 6 | 2022 | 72334 | 0.070 |
Why?
|
Adipose Tissue | 1 | 2019 | 3312 | 0.070 |
Why?
|
Cholesterol | 1 | 2016 | 2904 | 0.070 |
Why?
|
Genetic Testing | 1 | 2020 | 3537 | 0.070 |
Why?
|
Developmental Disabilities | 1 | 2015 | 1509 | 0.070 |
Why?
|
Treatment Outcome | 8 | 2024 | 64680 | 0.070 |
Why?
|
Bone Marrow | 1 | 2017 | 2911 | 0.070 |
Why?
|
Metaphase | 1 | 2005 | 145 | 0.060 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2021 | 3708 | 0.060 |
Why?
|
Follow-Up Studies | 5 | 2024 | 39106 | 0.060 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12463 | 0.060 |
Why?
|
Mutation | 2 | 2020 | 30052 | 0.060 |
Why?
|
Karyotyping | 1 | 2005 | 1171 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2021 | 4761 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3688 | 0.050 |
Why?
|
Endothelial Cells | 1 | 2015 | 3548 | 0.050 |
Why?
|
Adult | 8 | 2023 | 221177 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10194 | 0.050 |
Why?
|
Neprilysin | 1 | 2024 | 478 | 0.050 |
Why?
|
Echocardiography, Stress | 1 | 2022 | 134 | 0.050 |
Why?
|
Milrinone | 1 | 2021 | 86 | 0.050 |
Why?
|
Catheter Ablation | 1 | 2015 | 2751 | 0.050 |
Why?
|
Anthracyclines | 1 | 2023 | 284 | 0.050 |
Why?
|
Prospective Studies | 5 | 2024 | 54425 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6484 | 0.050 |
Why?
|
Prognosis | 4 | 2022 | 29625 | 0.040 |
Why?
|
Age Factors | 2 | 2021 | 18395 | 0.040 |
Why?
|
Infant, Newborn | 4 | 2024 | 26198 | 0.040 |
Why?
|
Inflammation | 1 | 2019 | 10773 | 0.040 |
Why?
|
Kidney | 1 | 2015 | 7048 | 0.040 |
Why?
|
Cardiotonic Agents | 1 | 2021 | 539 | 0.040 |
Why?
|
Steroids | 1 | 2023 | 929 | 0.040 |
Why?
|
Boston | 2 | 2024 | 9326 | 0.040 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2024 | 1516 | 0.040 |
Why?
|
Organizational Policy | 1 | 2020 | 432 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11460 | 0.040 |
Why?
|
Transcription Factors | 1 | 2017 | 12128 | 0.030 |
Why?
|
Mice, Inbred C57BL | 1 | 2015 | 22169 | 0.030 |
Why?
|
Respiration Disorders | 1 | 2019 | 367 | 0.030 |
Why?
|
Employment | 1 | 2023 | 1118 | 0.030 |
Why?
|
Exercise | 1 | 2013 | 5890 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18252 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2024 | 1723 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2024 | 12341 | 0.030 |
Why?
|
Registries | 1 | 2011 | 8224 | 0.030 |
Why?
|
Treatment Failure | 1 | 2021 | 2645 | 0.030 |
Why?
|
Survival Rate | 2 | 2021 | 12725 | 0.030 |
Why?
|
Intelligence Tests | 1 | 2015 | 503 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2019 | 1870 | 0.030 |
Why?
|
Endothelin-1 | 1 | 2015 | 302 | 0.030 |
Why?
|
Bronchoscopy | 1 | 2019 | 909 | 0.030 |
Why?
|
Reoperation | 1 | 2024 | 4303 | 0.030 |
Why?
|
Phlebography | 1 | 2015 | 326 | 0.030 |
Why?
|
Sample Size | 1 | 2017 | 841 | 0.030 |
Why?
|
Cohort Studies | 2 | 2017 | 41487 | 0.030 |
Why?
|
Incidence | 1 | 2011 | 21353 | 0.030 |
Why?
|
Survivors | 1 | 2023 | 2371 | 0.030 |
Why?
|
Middle Aged | 6 | 2020 | 220895 | 0.030 |
Why?
|
Societies, Medical | 1 | 2024 | 3905 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2024 | 5112 | 0.020 |
Why?
|
Vascular Patency | 1 | 2015 | 911 | 0.020 |
Why?
|
Survival Analysis | 1 | 2024 | 10090 | 0.020 |
Why?
|
Leukocytes | 1 | 2019 | 2026 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2015 | 1096 | 0.020 |
Why?
|
Aspirin | 1 | 2023 | 3133 | 0.020 |
Why?
|
Angioplasty, Balloon | 1 | 2015 | 589 | 0.020 |
Why?
|
Hemodynamics | 1 | 2021 | 4159 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20098 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2015 | 803 | 0.020 |
Why?
|
Chronic Disease | 2 | 2015 | 9318 | 0.020 |
Why?
|
Administration, Inhalation | 1 | 2013 | 1157 | 0.020 |
Why?
|
Continuity of Patient Care | 1 | 2017 | 1069 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2019 | 5869 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7827 | 0.020 |
Why?
|
Program Evaluation | 1 | 2017 | 2495 | 0.020 |
Why?
|
Electrocardiography | 1 | 2021 | 6377 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2020 | 3096 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4575 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2016 | 1496 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5035 | 0.020 |
Why?
|
Aged | 4 | 2020 | 169289 | 0.020 |
Why?
|
Radiography, Interventional | 1 | 2015 | 1121 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4812 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7390 | 0.020 |
Why?
|
Models, Biological | 1 | 2023 | 9469 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2013 | 2078 | 0.020 |
Why?
|
Equipment Design | 1 | 2015 | 3510 | 0.020 |
Why?
|
Animals | 2 | 2015 | 168459 | 0.020 |
Why?
|
Patient Care Team | 1 | 2017 | 2521 | 0.020 |
Why?
|
Exercise Test | 1 | 2013 | 2127 | 0.020 |
Why?
|
Macrophages | 1 | 2019 | 5769 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2015 | 5247 | 0.010 |
Why?
|
Stents | 1 | 2015 | 3179 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16591 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15842 | 0.010 |
Why?
|
Asthma | 1 | 2019 | 6234 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 12795 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 10209 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9420 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8002 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13506 | 0.010 |
Why?
|
MicroRNAs | 1 | 2015 | 3816 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17904 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22176 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2015 | 4811 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 11903 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36426 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20570 | 0.010 |
Why?
|